Todd M. Durell

651 total citations
17 papers, 496 citations indexed

About

Todd M. Durell is a scholar working on Psychiatry and Mental health, Cognitive Neuroscience and Pharmacology. According to data from OpenAlex, Todd M. Durell has authored 17 papers receiving a total of 496 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Psychiatry and Mental health, 6 papers in Cognitive Neuroscience and 3 papers in Pharmacology. Recurrent topics in Todd M. Durell's work include Attention Deficit Hyperactivity Disorder (13 papers), Bipolar Disorder and Treatment (6 papers) and Neural and Behavioral Psychology Studies (5 papers). Todd M. Durell is often cited by papers focused on Attention Deficit Hyperactivity Disorder (13 papers), Bipolar Disorder and Treatment (6 papers) and Neural and Behavioral Psychology Studies (5 papers). Todd M. Durell collaborates with scholars based in United States, Colombia and Puerto Rico. Todd M. Durell's co-authors include Lenard A. Adler, Ahmed Deldar, Kory Schuh, Richard L. Rubin, Paul E.A. Glaser, Meihua Qiao, Larry A. Kroutil, David L. Van Brunt, Michael R. Liebowitz and William G. Kronenberger and has published in prestigious journals such as PLoS ONE, Psychopharmacology and The Journal of Clinical Psychiatry.

In The Last Decade

Todd M. Durell

17 papers receiving 474 citations

Peers

Todd M. Durell

PMH

CN

CP

CMN

PHARM

Bryan Dirks United States

Joseph S. English United States

Maija Konstenius Sweden

Sharon Kowalik United States

Bailey Munro United States

Anna M. Monk United Kingdom

Jilian M. Mulqueen United States

Luc Nicole Canada

Kenneth B. Benedict United States

Thiago Gatti Pianca Brazil

Bryan Dirks United States

Todd M. Durell

492 ×1.3

PMH

211 ×0.9

CN

141 ×1.5

CP

90 ×1.2

CMN

82 ×1.1

PHARM

Citations per year, relative to Todd M. Durell Todd M. Durell (= 1×) peers Bryan Dirks

Countries citing papers authored by Todd M. Durell

Since Specialization

Citations

This map shows the geographic impact of Todd M. Durell's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Todd M. Durell with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Todd M. Durell more than expected).

Fields of papers citing papers by Todd M. Durell

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Todd M. Durell. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Todd M. Durell. The network helps show where Todd M. Durell may publish in the future.

Co-authorship network of co-authors of Todd M. Durell

This figure shows the co-authorship network connecting the top 25 collaborators of Todd M. Durell. A scholar is included among the top collaborators of Todd M. Durell based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Todd M. Durell. Todd M. Durell is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

17 of 17 papers shown

1.

Leuchter, Andrew F., James J. McGough, Alexander S. Korb, et al.. (2014). Neurophysiologic predictors of response to atomoxetine in young adults with attention deficit hyperactivity disorder: A pilot project. Journal of Psychiatric Research. 54. 11–18. 19 indexed citations

2.

Adler, Lenard A., David B. Clemow, David W. Williams, & Todd M. Durell. (2014). Atomoxetine Effects on Executive Function as Measured by the BRIEF-A in Young Adults with ADHD: A Randomized, Double-Blind, Placebo-Controlled Study. PLoS ONE. 9(8). e104175–e104175. 23 indexed citations

3.

Upadhyaya, Himanshu P., D. Desaiah, Kory Schuh, et al.. (2013). A review of the abuse potential assessment of atomoxetine: a nonstimulant medication for attention-deficit/hyperactivity disorder. Psychopharmacology. 226(2). 189–200. 44 indexed citations

4.

Adler, Lenard A., Timothy E. Wilens, Shuyu Zhang, et al.. (2012). Atomoxetine Treatment Outcomes in Adolescents and Young Adults With Attention-Deficit/Hyperactivity Disorder: Results From a Post Hoc, Pooled Analysis. Clinical Therapeutics. 34(2). 363–373. 10 indexed citations

5.

Durell, Todd M., Lenard A. Adler, Ahmed Deldar, et al.. (2012). Atomoxetine Treatment of Attention-Deficit/Hyperactivity Disorder in Young Adults With Assessment of Functional Outcomes. Journal of Clinical Psychopharmacology. 33(1). 45–54. 51 indexed citations

6.

Stauffer, Virginia L., Jennifer Gatz, Sara Kollack‐Walker, et al.. (2010). Impact of race on efficacy and safety during treatment with olanzapine in schizophrenia, schizophreniform or schizoaffective disorder. BMC Psychiatry. 10(1). 89–89. 20 indexed citations

7.

Upadhyaya, Himanshu P., Larry A. Kroutil, Deborah Deas, et al.. (2010). Stimulant Formulation and Motivation for Nonmedical Use of Prescription Attention‐Deficit/Hyperactivity Disorder Medications in a College‐Aged Population. American Journal on Addictions. 19(6). 569–577. 32 indexed citations

8.

Degenhardt, Elisabeth K., et al.. (2010). Relationship between African–American or Caucasian origin and outcomes in the olanzapine treatment of acute mania. International Clinical Psychopharmacology. 26(3). 141–145. 1 indexed citations

9.

Tohen, Mauricio, et al.. (2010). Olanzapine/Fluoxetine Combination in Patients With Treatment-Resistant Depression. The Journal of Clinical Psychiatry. 71(4). 451–462. 32 indexed citations

10.

Adler, Lenard A., Michael R. Liebowitz, William G. Kronenberger, et al.. (2009). Atomoxetine treatment in adults with attention-deficit/hyperactivity disorder and comorbid social anxiety disorder. Depression and Anxiety. 26(3). 212–221. 119 indexed citations

11.

Adler, Lenard A., Timothy E. Wilens, Shuyu Zhang, et al.. (2009). Retrospective Safety Analysis of Atomoxetine in Adult ADHD Patients with or without Comorbid Alcohol Abuse and Dependence. American Journal on Addictions. 18(5). 393–401. 21 indexed citations

12.

Durell, Todd M., et al.. (2009). Atomoxetine Treatment for ADHD. Journal of Attention Disorders. 13(4). 401–406. 16 indexed citations

13.

Durell, Todd M., et al.. (2009). Effects of Open-Label Atomoxetine on African-American and Caucasian Pediatric Outpatients with Attention-Deficit/Hyperactivity Disorder. Annals of Clinical Psychiatry. 21(1). 26–37. 17 indexed citations

14.

Adler, Lenard A., Timothy E. Wilens, Shuyu Zhang, et al.. (2009). Retrospective Safety Analysis of Atomoxetine in Adult ADHD Patients with or without Comorbid Alcohol Abuse and Dependence. American Journal on Addictions. 18(5). 393–401. 1 indexed citations

15.

Pumariega, Andrés J., Eugenio M. Rothe, Douglas K. Kelsey, et al.. (2008). Latino Versus Caucasian Response to Atomoxetine in Attention-Deficit/Hyperactivity Disorder. Journal of Child and Adolescent Psychopharmacology. 18(1). 44–53. 18 indexed citations

16.

Durell, Todd M., et al.. (2008). Prevalence of nonmedical methamphetamine use in the United States. Substance Abuse Treatment Prevention and Policy. 3(1). 19–19. 40 indexed citations

17.

Lile, Joshua A., William W. Stoops, Todd M. Durell, Paul E.A. Glaser, & Craig R. Rush. (2006). Discriminative-stimulus, self-reported, performance, and cardiovascular effects of atomoxetine in methylphenidate-trained humans.. Experimental and Clinical Psychopharmacology. 14(2). 136–147. 32 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact